Page last updated: 2024-08-24

nelfinavir and Lymphoma

nelfinavir has been researched along with Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bader, J; Berset, C; Berthod, G; Driessen, C; Hawle, H; Hess, D; Hitz, F; Huitema, A; Joerger, M; Kraus, M; Mey, UJ; Overkleeft, HS; Pabst, T; Rosing, H; Sessa, C; von Moos, R; Xyrafas, A	1

Trials

1 trial(s) available for nelfinavir and Lymphoma

Article	Year
Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08). Haematologica, 2016, Volume: 101, Issue:3 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Drug Administration Schedule; Drug Combinations; Drug Resistance, Neoplasm; Female; HIV Protease Inhibitors; Humans; Leukemia; Leukocytes, Mononuclear; Lymphoma; Male; Middle Aged; Multiple Myeloma; Nelfinavir; Proteasome Endopeptidase Complex; Treatment Outcome; Unfolded Protein Response	2016

Article

Year

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08).

Haematologica, 2016, Volume: 101, Issue:3

Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Drug Administration Schedule; Drug Combinations; Drug Resistance, Neoplasm; Female; HIV Protease Inhibitors; Humans; Leukemia; Leukocytes, Mononuclear; Lymphoma; Male; Middle Aged; Multiple Myeloma; Nelfinavir; Proteasome Endopeptidase Complex; Treatment Outcome; Unfolded Protein Response

2016